Cargando…

Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance

OBJECTIVE: Resting Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) brain imaging and neuropsychological testing were used to investigate the usefulness of a spatial navigation task (SNT) as a performance benchmark for cognitive impairment related to anti-N-methyl D-aspartate (a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ploran, Elisabeth, Tang, Chris, Mackay, Meggan, Small, Michael, Anderson, Erik, Storbeck, Justin, Bascetta, Brittany, Kang, Simran, Aranow, Cynthia, Sartori, Carl, Watson, Philip, Volpe, Bruce, Diamond, Betty, Eidelberg, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667777/
https://www.ncbi.nlm.nih.gov/pubmed/31413849
http://dx.doi.org/10.1136/lupus-2019-000327
_version_ 1783440096576405504
author Ploran, Elisabeth
Tang, Chris
Mackay, Meggan
Small, Michael
Anderson, Erik
Storbeck, Justin
Bascetta, Brittany
Kang, Simran
Aranow, Cynthia
Sartori, Carl
Watson, Philip
Volpe, Bruce
Diamond, Betty
Eidelberg, David
author_facet Ploran, Elisabeth
Tang, Chris
Mackay, Meggan
Small, Michael
Anderson, Erik
Storbeck, Justin
Bascetta, Brittany
Kang, Simran
Aranow, Cynthia
Sartori, Carl
Watson, Philip
Volpe, Bruce
Diamond, Betty
Eidelberg, David
author_sort Ploran, Elisabeth
collection PubMed
description OBJECTIVE: Resting Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) brain imaging and neuropsychological testing were used to investigate the usefulness of a spatial navigation task (SNT) as a performance benchmark for cognitive impairment related to anti-N-methyl D-aspartate (anti-NMDA) receptor antibodies (DNRAb) in SLE. METHODS: Neuropsychological assessments, including a desktop 3-D virtual SNT, were performed on 19 SLE participants and 9 healthy control (HC) subjects. SLE participants had stable disease activity and medication doses and no history of neuropsychiatric illness or current use of mind-altering medications. Resting FDG-PET scans were obtained on all SLE participants and compared with a historical set from 25 age-matched and sex-matched HCs. Serum DNRAb titres were measured by ELISA. RESULTS: 11/19 (58%) of SLE participants failed to complete the SNT (SNT−) compared with 2/9 (22%) of HCs. Compared with 7/9 (78%) in HCs, only 2/9 (22%; p=0.037) of SLE participants with high serum DNRAb titres completed the SNT, in contrast to 6/10 (60%; p=0.810) in SLE participants with low DNRAb titres. Voxel-wise comparison of FDG-PET scans between the 8 SLE participants successfully completing the SNT task (SNT+) and the 11 SNT− SLE participants revealed increased metabolism in the SNT+ participants (p<0.001) in the left anterior putamen/caudate, right anterior putamen, left prefrontal cortex (BA 9), right prefrontal cortex (BA 9/10) and left lateral and medial frontal cortex (BA 8). Compared with HCs, the SNT+ group demonstrated increased metabolism in all regions (p<0.02) except for the right prefrontal cortex (BA 9), whereas the SNT− group demonstrated either significantly decreased or similar metabolism in these seven regions. CONCLUSIONS: SNT performance is associated with serum DNRAb titres and resting glucose metabolism in the anterior putamen/caudate and frontal cortex, suggesting compensatory neural recruitment in SNT-associated regions is necessary for successful completion of the task. The SNT therefore has potential for use as a marker for SLE-mediated cognitive impairment.
format Online
Article
Text
id pubmed-6667777
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66677772019-08-14 Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance Ploran, Elisabeth Tang, Chris Mackay, Meggan Small, Michael Anderson, Erik Storbeck, Justin Bascetta, Brittany Kang, Simran Aranow, Cynthia Sartori, Carl Watson, Philip Volpe, Bruce Diamond, Betty Eidelberg, David Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: Resting Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) brain imaging and neuropsychological testing were used to investigate the usefulness of a spatial navigation task (SNT) as a performance benchmark for cognitive impairment related to anti-N-methyl D-aspartate (anti-NMDA) receptor antibodies (DNRAb) in SLE. METHODS: Neuropsychological assessments, including a desktop 3-D virtual SNT, were performed on 19 SLE participants and 9 healthy control (HC) subjects. SLE participants had stable disease activity and medication doses and no history of neuropsychiatric illness or current use of mind-altering medications. Resting FDG-PET scans were obtained on all SLE participants and compared with a historical set from 25 age-matched and sex-matched HCs. Serum DNRAb titres were measured by ELISA. RESULTS: 11/19 (58%) of SLE participants failed to complete the SNT (SNT−) compared with 2/9 (22%) of HCs. Compared with 7/9 (78%) in HCs, only 2/9 (22%; p=0.037) of SLE participants with high serum DNRAb titres completed the SNT, in contrast to 6/10 (60%; p=0.810) in SLE participants with low DNRAb titres. Voxel-wise comparison of FDG-PET scans between the 8 SLE participants successfully completing the SNT task (SNT+) and the 11 SNT− SLE participants revealed increased metabolism in the SNT+ participants (p<0.001) in the left anterior putamen/caudate, right anterior putamen, left prefrontal cortex (BA 9), right prefrontal cortex (BA 9/10) and left lateral and medial frontal cortex (BA 8). Compared with HCs, the SNT+ group demonstrated increased metabolism in all regions (p<0.02) except for the right prefrontal cortex (BA 9), whereas the SNT− group demonstrated either significantly decreased or similar metabolism in these seven regions. CONCLUSIONS: SNT performance is associated with serum DNRAb titres and resting glucose metabolism in the anterior putamen/caudate and frontal cortex, suggesting compensatory neural recruitment in SNT-associated regions is necessary for successful completion of the task. The SNT therefore has potential for use as a marker for SLE-mediated cognitive impairment. BMJ Publishing Group 2019-07-11 /pmc/articles/PMC6667777/ /pubmed/31413849 http://dx.doi.org/10.1136/lupus-2019-000327 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology and Outcomes
Ploran, Elisabeth
Tang, Chris
Mackay, Meggan
Small, Michael
Anderson, Erik
Storbeck, Justin
Bascetta, Brittany
Kang, Simran
Aranow, Cynthia
Sartori, Carl
Watson, Philip
Volpe, Bruce
Diamond, Betty
Eidelberg, David
Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
title Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
title_full Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
title_fullStr Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
title_full_unstemmed Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
title_short Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
title_sort assessing cognitive impairment in sle: examining relationships between resting glucose metabolism and anti-nmdar antibodies with navigational performance
topic Epidemiology and Outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667777/
https://www.ncbi.nlm.nih.gov/pubmed/31413849
http://dx.doi.org/10.1136/lupus-2019-000327
work_keys_str_mv AT ploranelisabeth assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT tangchris assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT mackaymeggan assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT smallmichael assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT andersonerik assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT storbeckjustin assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT bascettabrittany assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT kangsimran assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT aranowcynthia assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT sartoricarl assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT watsonphilip assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT volpebruce assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT diamondbetty assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance
AT eidelbergdavid assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance